Department of Veterans Affairs Awarded a Contract to NOVARTIS PHARMACEUTICALS CORPORATION for $33,838.23

Q: Where is NOVARTIS PHARMACEUTICALS CORPORATION located?

59 ROUTE 10 EAST HANOVER NEW JERSEY UNITED STATES

Signed on

4/11/2025, 12:00 AM

NOVARTIS PHARMACEUTICALS CORPORATION Government Contract #36C24525N0558

NOVARTIS PHARMACEUTICALS CORPORATION was awarded a contract with the United States Government for $33,838.23. The contract was awarded by the agency office 245-NETWORK CONTRACT OFFICE 5 (36C245), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is Novartis Pharmaceuticals Corporation, a U.S.-owned business that manufactures pharmaceuticals. The contract is for FabhAlta 200 mg, funded by the Department of Veterans Affairs, with a total worth of $33,838.23. The contract transaction on April 11, 2025, shows a single transaction amount of $33,838.23 with no additional spending details provided.

Contract Details

Contract ID36C24525N0558

Contract TypeC

Total Obligation$33,838.23

Exercised Options$33,838.23

Base Amount + Options$33,838.23

Date Signed2025-04-11

Contract DescriptionFABHALTA 200 MG

Start Date2025-04-11

End Date2025-04-18

Agency Details

Awarding AgencyDepartment of Veterans Affairs

Awarding Sub AgencyDepartment of Veterans Affairs

Awarding Office245-NETWORK CONTRACT OFFICE 5 (36C245)

Funding AgencyDepartment of Veterans Affairs

Funding Sub AgencyDepartment of Veterans Affairs

Funding Office512-BALTIMORE(00512)(36C512)

Recipient Details

RecipientNOVARTIS PHARMACEUTICALS CORPORATION

Recipient Location59 ROUTE 10 EAST HANOVER NEW JERSEY, UNITED STATES

Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0 | $33,838.23April 11, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $33,838.23 to NOVARTIS PHARMACEUTICALS CORPORATION. The payment included a Subsidy Cost of $0.00.